Ceradyne's Q4 earnings call highlighted significant challenges, including declining sales and net income, and a substantial reduction in 2009 guidance. Delays in key military contracts like the XSAPI armor orders and uncertainties in the industrial markets, particularly in Europe, contribute to a negative short-term outlook. These factors are likely to put considerable downward pressure on the stock price in the next 1â€“2 weeks.

[-2]